Atlas Venture Fund V Lp - Net Worth and Insider Trading
Atlas Venture Fund V Lp Net Worth
The estimated net worth of Atlas Venture Fund V Lp is at least $10 Million dollars as of 2024-05-21. Atlas Venture Fund V Lp is the 10% Owner of NxStage Medical Inc and owns about 218,944 shares of NxStage Medical Inc (NXTM) stock worth over $7 Million. Atlas Venture Fund V Lp is also the 10% Owner of Momenta Pharmaceuticals Inc and owns about 73,201 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $4 Million. Details can be seen in Atlas Venture Fund V Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Atlas Venture Fund V Lp has not made any transactions after 2005-10-27 and currently still holds the listed stock(s).
Transaction Summary of Atlas Venture Fund V Lp
Atlas Venture Fund V Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Fund V Lp owns 4 companies in total, including Achillion Pharmaceuticals Inc (ACHN) , Alnylam Pharmaceuticals Inc (ALNY) , and NxStage Medical Inc (NXTM) among others .
Click here to see the complete history of Atlas Venture Fund V Lp’s form 4 insider trades.
Insider Ownership Summary of Atlas Venture Fund V Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | 2006-10-31 | 10 percent owner |
| ALNY | Alnylam Pharmaceuticals Inc | 2004-05-27 | 10 percent owner |
| NXTM | NxStage Medical Inc | 2005-11-01 | 10 percent owner |
 | | 2005-08-03 | 10 percent owner |
Atlas Venture Fund V Lp Latest Holdings Summary
Atlas Venture Fund V Lp currently owns a total of 2 stocks. Among these stocks, Atlas Venture Fund V Lp owns 218,944 shares of NxStage Medical Inc (NXTM) as of October 27, 2005, with a value of $7 Million and a weighting of 63.1%. Atlas Venture Fund V Lp also owns 73,201 shares of Momenta Pharmaceuticals Inc (MNTA) as of June 21, 2004, with a value of $4 Million and a weighting of 36.9%.
Latest Holdings of Atlas Venture Fund V Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NXTM | NxStage Medical Inc | 2005-10-27 | 218,944 | 30.00 | 6,568,320 |
| MNTA | Momenta Pharmaceuticals Inc | 2004-06-21 | 73,201 | 52.48 | 3,841,588 |
Holding Weightings of Atlas Venture Fund V Lp
Atlas Venture Fund V Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Atlas Venture Fund V Lp has made a total of 0 transactions in NxStage Medical Inc (NXTM) over the past 5 years. The most-recent trade in NxStage Medical Inc is the acquisition of 99,923 shares on October 27, 2005, which cost Atlas Venture Fund V Lp around $999,230.
According to the SEC Form 4 filings, Atlas Venture Fund V Lp has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the acquisition of 244,000 shares on June 21, 2004, which cost Atlas Venture Fund V Lp around $2 Million.
Insider Trading History of Atlas Venture Fund V Lp
- 1
Atlas Venture Fund V Lp Trading Performance
GuruFocus tracks the stock performance after each of Atlas Venture Fund V Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Atlas Venture Fund V Lp is 1.02%. GuruFocus also compares Atlas Venture Fund V Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Atlas Venture Fund V Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Atlas Venture Fund V Lp's insider trading performs compared to the benchmark.
Performance of Atlas Venture Fund V Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.33 | | | | | |
| Relative Return to S&P 500(%) | 8.75 | | | | | |
Atlas Venture Fund V Lp Ownership Network
Atlas Venture Fund V Lp Owned Company Details
What does Achillion Pharmaceuticals Inc do?
Who are the key executives at Achillion Pharmaceuticals Inc?
Atlas Venture Fund V Lp is the 10 percent owner of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Commercial Officer Paul E Firuta , EVP & Chief Medical Officer Steven Zelenkofske , and General Counsel Martha E Manning .
Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Achillion Pharmaceuticals Inc Insider Transactions
Atlas Venture Fund V Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Atlas Venture Fund V Lp. Currently GuruFocus does not have mailing address information for Atlas Venture Fund V Lp.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
